Bishop Thomas Supports Bill to End FDA Approval of Chemical Abortion Pills
“The abortion pill represents an isolating and harmful response to women in need,” said Bishop Daniel E. Thomas, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities.
WASHINGTON – “The abortion pill represents an isolating and harmful response to women in need,” said Bishop Daniel E. Thomas, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities. On Wednesday, Bishop Thomas wrote a letter to Congress in support of the “Safeguarding Women from Chemical Abortion Act,” which was recently introduced by Senator Josh Hawley and Representative Diana Harshbarger. The bill (S.4066/H.R.7902) would withdraw the U.S. Food and Drug Administration’s (FDA) approval of mifepristone for abortions.
In his letter, Bishop Thomas stated that the bill would likely save lives by curtailing the incidence of chemical abortion itself as well as its associated risks to the mothers. He emphasized the bishops’ opposition to the chemical abortion drug not only for its purpose of terminating life, but that the abortion pill represents an isolating and harmful response to women in need.
Read Bishop Thomas’ letter here.
###
